Background illustration for clinical trials search

Paid Clinical Trials Killeen

Discover 701 paid clinical trials in Killeen, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome

for
Dravet Syndrome
Location: Austin TX, Little Rock AR, Birmingham AL, Omaha NE,
Sponsor: Epygenix

Sex: All

Age: 2+

Code: NCT04462770

Phase 3, Recruiting

Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

for
Acute Treatment of Migraine
Location: Austin TX, Houston TX, Bellaire TX, El Paso TX,
Sponsor: Pfizer

Sex: All

Age: 6 - 17

Code: NCT04743141

Phase 3, Recruiting

Predicting Rehabilitation Outcomes in Bilingual Aphasia Using Computational Modeling

for
Aphasia
Location: Austin TX, San Francisco CA, Boston MA
Sponsor: Boston University Charles River Campus

Sex: All

Age: 18 - 70+

Code: NCT02916524

Recruiting

Assessing Pediatric Food Insecurity During the COVID-19 Pandemic in Austin

for
Food Insecurity
Location: Austin TX
Sponsor: University of Texas at Austin

Sex: All

Age: 18 - 70+

Code: NCT04378595

Recruiting

A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia

for
Narcolepsy Type 1, Narcolepsy Type 2, Idiopathic Hypersomnia
Location: Austin TX, San Antonio TX, New Orleans LA, El Paso TX,
Sponsor: Centessa Pharmaceuticals (UK) Limited

Sex: All

Age: 18 - 65

Code: NCT06752668

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence

for
Narcolepsy Type 1, Narcolepsy Type 2
Location: Austin TX, San Antonio TX, Dallas TX, Houston TX,
Sponsor: Centessa Pharmaceuticals (UK) Limited

Sex: All

Age: 18 - 70

Code: NCT07598708

Phase 2, Phase 3, Recruiting

A Study of TAK-360 in People With Narcolepsy or Idiopathic Hypersomnia

for
Idiopathic Hypersomnia, Narcolepsy Type 1, Narcolepsy Type 2
Location: Austin TX, San Antonio TX, St Louis MO,
Sponsor: Takeda

Sex: All

Age: 18 - 70+

Code: NCT07646678

Phase 2, Phase 3, Recruiting

A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1

for
Narcolepsy Type 1
Location: Austin TX, San Antonio TX, Sugar Land TX,
Sponsor: Alkermes, Inc.

Sex: All

Age: 18 - 70

Code: NCT07455383

Phase 3, Recruiting

A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2

for
Narcolepsy Type 2
Location: Austin TX, San Antonio TX, Frisco TX, Sugar Land TX,
Sponsor: Alkermes, Inc.

Sex: All

Age: 18 - 70

Code: NCT07502443

Phase 3, Recruiting

A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia

for
Narcolepsy Type 1, Narcolepsy Type 2, Idiopathic Hypersomnia
Location: Austin TX, San Antonio TX, Dallas TX, Sugar Land TX,
Sponsor: Alkermes, Inc.

Sex: All

Age: 18 - 70

Code: NCT06767683

Phase 2, Phase 3, Recruiting

A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)

for
Narcolepsy Type 2
Location: Austin TX, San Antonio TX, Colorado Springs CO,
Sponsor: Takeda

Sex: All

Age: 18 - 70

Code: NCT06952699

Phase 2, Recruiting

Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia

for
Schizophrenia
Location: Austin TX, Richardson TX, Oklahoma City OK,
Sponsor: Reviva Pharmaceuticals

Sex: All

Age: 18 - 65

Code: NCT05184335

Phase 3, Recruiting

Randomized Withdrawal Study in Patients With Schizophrenia

for
Schizophrenia
Location: Austin TX, Irving TX, Richardson TX, Houston TX,
Sponsor: Vanda Pharmaceuticals

Sex: All

Age: 18 - 65

Code: NCT06961968

Phase 3, Recruiting

Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.

for
Relapsing Multiple Sclerosis
Location: Austin TX, Fort Worth TX, Dallas TX, Plano TX,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 40 - 70

Code: NCT06846281

Phase 3, Recruiting

Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes

for
Type 1 Diabetes (T1D), Type 2 Diabetes (T2D)
Location: Austin TX, Sandy City UT, Detroit MI, Morehead City NC,
Sponsor: DreaMed Diabetes

Sex: All

Age: 18 - 70+

Code: NCT07599982

Recruiting

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Austin TX, Fort Worth TX, San Antonio TX, Tyler TX,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06136559

Phase 3, Recruiting

A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer

for
Low Grade Serous Ovarian Cancer
Location: Austin TX, Fort Worth TX, San Antonio TX,
Sponsor: Verastem, Inc.

Sex: Female

Age: 18+

Code: NCT06072781

Phase 3, Recruiting

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

for
Melanoma
Location: Austin TX, Fort Worth TX, Bedford TX, Dallas TX,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06246916

Phase 3, Recruiting

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

for
High Grade Epithelial Ovarian Cancer,
Location: Austin TX, Fort Worth TX, Dallas TX, Abilene TX,
Sponsor: Genmab

Sex: All

Age: 18+

Code: NCT05579366

Phase 1, Phase 2, Recruiting

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

for
Ovarian Cancer, Fallopian Tube Cancer,
Location: Austin TX, Fort Worth TX, San Antonio TX, Webster TX,
Sponsor: Merck Sharp & Dohme LLC

Sex: Female

Age: 18+

Code: NCT06824467

Phase 3, Recruiting